| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Istituto di Citomorfologia Normale e Patologica, CNR, 40136 Bologna, Italy [C. C., L. M. N., N. M. M.]; Departments of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 [P. P. C., C. M. H., Y. F., A. G.]; Dipartimento di Scienze Odontostomatologiche e Maxillo-Facciali, Università di Napoli "Federico II," 80100 Naples, Italy [P. P. C.]; Istituto di Anatomia Umana Normale, Università di Ferrara, 44100 Ferrara, Italy [L. M. N.]; Laboratorio di Biologia Cellulare e Microscopia Elettronica, Istituti di Ricerca "Codivilla Putti," IOR, 40100 Bologna, Italy [N. M. M.]; and Istituto di Anatomia e Istologia Patologica [L. L.] and Dipartimento di Scienze Oftalmologiche e Neurochirurgiche [G. M. T.], Università di Siena, 53100 Siena, Italy
The prototypic tumor suppressor gene, the retinoblastoma gene (RB/p105), is mutated in a variety of human tumors. However, to date, mutational data on retinoblastoma family members p107 and RB2/p130 in tumors is lacking. We studied the expression of pRb2/p130 by immunocytochemistry and Western blot analysis in a panel of human osteosarcoma and lymphoid cell lines. Only the lymphoid cell lines showed an abnormal cytoplasmic localization of pRb2/p130, suggesting possible alterations within the region of nuclear localization signaling. We screened these cell lines for genetic alterations of the RB2/p130 gene in the region of the putative bipartite nuclear localization signal (NLS). This region is highly homologous with that of the RB/p105 gene. In addition, we screened four primary Burkitts lymphomas for genetic alterations in the RB2/p130 gene. Naturally occurring mutations, which disrupt the putative bipartite NLS, were found in lymphoma cell lines and primary tumors, but not in the osteosarcoma cell lines, where normal nuclear localization of the protein was detectable. Site-directed mutagenesis and transfection assay using NLS mutants displayed markedly reduced biological activity as measured by flow cytometric analysis. This study clearly describes RB2/p130as an important target for mutations and subsequent inactivation in lymphoma pathogenesis, thus validating that RB2/p130 is a classical tumor suppressor gene.
This article has been cited by other articles:
![]() |
G Brady, G J MacArthur, and P J Farrell Epstein-Barr virus and Burkitt lymphoma Postgrad. Med. J., July 1, 2008; 84(993): 372 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Nguyen, A. N. Loveland, and W. Gibson Nuclear Localization Sequences in Cytomegalovirus Capsid Assembly Proteins (UL80 Proteins) Are Required for Virus Production: Inactivating NLS1, NLS2, or Both Affects Replication to Strikingly Different Extents J. Virol., June 1, 2008; 82(11): 5381 - 5389. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Genovese, N. S. Banerjee, T. R. Broker, and L. T. Chow Casein Kinase II Motif-Dependent Phosphorylation of Human Papillomavirus E7 Protein Promotes p130 Degradation and S-Phase Induction in Differentiated Human Keratinocytes J. Virol., May 15, 2008; 82(10): 4862 - 4873. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rossi, V. Caracciolo, G. Russo, K. Reiss, and A. Giordano Medulloblastoma: From Molecular Pathology to Therapy Clin. Cancer Res., February 15, 2008; 14(4): 971 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Brady, G J MacArthur, and P J Farrell Epstein Barr virus and Burkitt lymphoma J. Clin. Pathol., December 1, 2007; 60(12): 1397 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Falco, E. Leucci, D. Lenze, P. P. Piccaluga, P. P. Claudio, A. Onnis, G. Cerino, J. Nyagol, W. Mwanda, C. Bellan, et al. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors Blood, August 15, 2007; 110(4): 1301 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Kelly and A. B. Rickinson Burkitt Lymphoma: Revisiting the Pathogenesis of a Virus-Associated Malignancy Hematology, January 1, 2007; 2007(1): 277 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Russo, A. Zamparelli, C. M. Howard, C. Minimo, C. Bellan, G. Carillo, L. Califano, L. Leoncini, A. Giordano, and P. P. Claudio Expression of Cell Cycle-Regulated Proteins pRB2/p130, p107, E2F4, p27, and pCNA in Salivary Gland Tumors: Prognostic and Diagnostic Implications Clin. Cancer Res., May 1, 2005; 11(9): 3265 - 3273. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huynh Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinoma Carcinogenesis, August 1, 2004; 25(8): 1485 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Bellan, S Lazzi, G De Falco, A Nyongo, A Giordano, and L Leoncini Burkitt's lymphoma: new insights into molecular pathogenesis J. Clin. Pathol., March 1, 2003; 56(3): 188 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bellan, G. De Falco, G. M. Tosi, S. Lazzi, F. Ferrari, G. Morbini, S. Bartolomei, P. Toti, P. Mangiavacchi, G. Cevenini, et al. Missing Expression of pRb2/p130 in Human Retinoblastomas Is Associated with Reduced Apoptosis and Lesser Differentiation Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3602 - 3608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caputi, A. M. Groeger, V. Esposito, A. De Luca, V. Masciullo, A. Mancini, F. Baldi, E. Wolner, and A. Giordano Loss of pRb2/p130 Expression Is Associated with Unfavorable Clinical Outcome in Lung Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3850 - 3856. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Leoncini, S Lazzi, C Bellan, and P Tosi Cell kinetics and cell cycle regulation in lymphomas J. Clin. Pathol., September 1, 2002; 55(9): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
A J Alvi, R Hogg, J S Rader, M J Kuo, E R Maher, and F Latif Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer Mol. Pathol., June 1, 2002; 55(3): 153 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Claudio, A. Zamparelli, F. U. Garcia, L. Claudio, G. Ammirati, A. Farina, A. Bovicelli, G. Russo, G. G. Giordano, D. E. McGinnis, et al. Expression of Cell-Cycle-regulated Proteins pRb2/p130, p107, p27kip1, p53, mdm-2, and Ki-67 (MIB-1) in Prostatic Gland Adenocarcinoma Clin. Cancer Res., June 1, 2002; 8(6): 1808 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chestukhin, L. Litovchick, K. Rudich, and J. A. DeCaprio Nucleocytoplasmic Shuttling of p130/RBL2: Novel Regulatory Mechanism Mol. Cell. Biol., January 15, 2002; 22(2): 453 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Dimitrova and R. Berezney The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells J. Cell Sci., January 11, 2002; 115(21): 4037 - 4051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Paggi and A. Giordano Who Is the Boss in the Retinoblastoma Family? The Point of View of Rb2/p130, the Little Brother Cancer Res., June 1, 2001; 61(12): 4651 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Howard, P. P. Claudio, Antonio De Luca, P. Stiegler, F. P. Jori, N. M. Safdar, M. Caputi, K. Khalili, and A. Giordano Inducible pRb2/p130 Expression and Growth-suppressive Mechanisms: Evidence of a pRb2/p130, p27Kip1, and Cyclin E Negative Feedback Regulatory Loop Cancer Res., May 1, 2000; 60(10): 2737 - 2744. [Abstract] [Full Text] |
||||
![]() |
P. P. Claudio, M. Caputi, and A. Giordano The RB2/p130 Gene: The Latest Weapon in the War against Lung Cancer? Clin. Cancer Res., March 1, 2000; 6(3): 754 - 764. [Abstract] [Full Text] |
||||
![]() |
C. Cinti, L. Leoncini, A. Nyongo, F. Ferrari, S. Lazzi, C. Bellan, R. Vatti, A. Zamparelli, G. Cevenini, G. M. T osi, et al. Genetic Alterations of the Retinoblastoma-Related Gene RB2/p130 Identify Different Pathogenetic Mechanisms in and among Burkitt’s Lymphoma Subtypes Am. J. Pathol., March 1, 2000; 156(3): 751 - 760. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |